Constellation Software Inc., together with its subsidiaries, acquires, builds, and manages vertical market software businesses in Canada, the United States, the United Kingdom, and rest of Europe. Its industry specific software businesses provide specialized and mission-critical software solutions. The company serves public and private sector markets. Constellation Software Inc. was incorporated in 1995 and is headquartered in Toronto, Canada.

Mark Leonard

Stephan Poirier

Constellation Software Inc.

ProGamma Science Corporation is a multidisciplinary company that provides comprehensive and economic solutions for technical operations and compliance in the pharmaceutical, biopharmaceutical, Natural Health Products, and medical devices industries. Self-described as offering high quality for client projects.

PROGAMMA SCIENCE

JatApp is an international IT company that develops and promotes its own mobile, desktop, and web products.

JatApp

Constellation Software is an international provider of market leading software and services to a select number of industries, both in the public and private sectors. Our mission is to acquire, manage and build market-leading software businesses that develop specialized, mission-critical software solutions to address the specific needs of our particular industries.

Our company was founded in 1995 to assemble a portfolio of vertical market software companies that have the potential to be leaders in their particular market. Since then, we have grown rapidly through a combination of acquisitions and organic growth, and established a strong group of companies with a large, diverse customer base.

We have six operating groups which manage hundreds of individual businesses.  Our businesses have offices globally that service customers in over 30 different markets worldwide,  We are headquartered in Toronto, Canada.

Metric
Company Name	Constellation Software Inc.	PROGAMMA SCIENCE	JatApp
Symbol	CSU
MSH ID	COM:CSISOFTWARE	CA:PROGAMMA	COM:JATAPP
Market	STOCKS	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services	Technology
Industry	Software - Application	Pharmaceuticals & Biopharmaceuticals	Information Technology
Country	CA	CA	US
Stage
Employee Count	45K
Website	csisoftware.com	progamma.ca	jatapp.com
LinkedIn	constellation-software-inc.	progamma
Founders

Metric
Market Cap	61.68B
Enterprise Value
Monthly Web Traffic	20.75K	10.21K
Web Traffic Growth	0.02	3.74
Valuation
Raised Capital	1B

Metric
Revenue	8.40B
Revenue (LTM)
Revenue (NTM)
Gross Profit	7.44B
EBITDA	1.46B
Operating Income	441M
Net Income	565M
EPS	26.67
Diluted EPS	26.67
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.89
Operating Profit Margin	0.10
EBITDA Margin	0.17
Net Profit Margin	0.07
Return on Equity	0.31
Return on Assets	0.05
Return on Capital Employed	0.13

COM:CSISOFTWARE

Constellation Software Inc.

Last Close

4,644.55

22/11 21:00

Market Cap

87.21B

Beta: -

Volume Today

22.46K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	162.46
P/B Ratio	34.32
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	7.76
EV Multiple	39.09

Metric
Days Sales Outstanding	71.15
Days Payables Outstanding	486.93
Days Inventory Outstanding	21.58
Operating Cycle	93.67
Cash Conversion Cycle	-364.96
Asset Turnover	0.77

Metric
Operating Cash Flow	1.78B
Free Cash Flow	1.74B
Cash Flow to Debt	0.48
Operating Cash Flow/Sales	0.22
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	1.28B
Accounts Receivable	-62M
Inventory	51M
Goodwill	1.27B
Debt to Capitalization	0.66
Debt to Assets	0.34
Current Ratio	0.58
Quick Ratio	0.91

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	-0.03
R&D to Revenue
SG&A to Revenue	0.61